Global Microneedle-based Drug Delivery System Market Growth 2020-2025
Apr, 2020
|
Report ID: 124872
|
159
|
Medical Devices
According to this study, over the next five years the Microneedle-based Drug Delivery System market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Microneedle-based Drug Delivery System business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Microneedle-based Drug Delivery System market by type, application, key manufacturers and key regions and countries.
This study considers the Microneedle-based Drug Delivery System value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Drug Delivery
Vaccine Delivery
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
3M
Vaxxas
Zosano Pharma
Nanopass Technologies
Corium
Becton-Dickinson_BD_Technologies
Microdermics
Valeritas
TheraJect
Nitto
Lohmann Therapie-Systeme AG
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Microneedle-based Drug Delivery System consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Microneedle-based Drug Delivery System market by identifying its various subsegments.
Focuses on the key global Microneedle-based Drug Delivery System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Microneedle-based Drug Delivery System with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Microneedle-based Drug Delivery System submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares, and growth opportunities of Microneedle-based Drug Delivery System market by type, application, key manufacturers and key regions and countries.
This study considers the Microneedle-based Drug Delivery System value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Drug Delivery
Vaccine Delivery
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
3M
Vaxxas
Zosano Pharma
Nanopass Technologies
Corium
Becton-Dickinson_BD_Technologies
Microdermics
Valeritas
TheraJect
Nitto
Lohmann Therapie-Systeme AG
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Microneedle-based Drug Delivery System consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Microneedle-based Drug Delivery System market by identifying its various subsegments.
Focuses on the key global Microneedle-based Drug Delivery System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Microneedle-based Drug Delivery System with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Microneedle-based Drug Delivery System submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microneedle-based Drug Delivery System Consumption 2015-2025
2.1.2 Microneedle-based Drug Delivery System Consumption CAGR by Region
2.2 Microneedle-based Drug Delivery System Segment by Type
2.2.1 Hollow Microneedle Technology
2.2.2 Solid Microneedle Technology
2.2.3 Dissolving Microneedles Technology
2.3 Microneedle-based Drug Delivery System Consumption by Type
2.3.1 Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
2.3.2 Global Microneedle-based Drug Delivery System Revenue and Market Share by Type (2015-2020)
2.3.3 Global Microneedle-based Drug Delivery System Sale Price by Type (2015-2020)
2.4 Microneedle-based Drug Delivery System Segment by Application
2.4.1 Drug Delivery
2.4.2 Vaccine Delivery
2.4.3 Other
2.5 Microneedle-based Drug Delivery System Consumption by Application
2.5.1 Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
2.5.2 Global Microneedle-based Drug Delivery System Value and Market Share by Type (2015-2020)
2.5.3 Global Microneedle-based Drug Delivery System Sale Price by Type (2015-2020)
3 Global Microneedle-based Drug Delivery System by Company
3.1 Global Microneedle-based Drug Delivery System Sales Market Share by Company
3.1.1 Global Microneedle-based Drug Delivery System Sales by Company (2018-2020)
3.1.2 Global Microneedle-based Drug Delivery System Sales Market Share by Company (2018-2020)
3.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Company
3.2.1 Global Microneedle-based Drug Delivery System Revenue by Company (2018-2020)
3.2.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Company (2018-2020)
3.3 Global Microneedle-based Drug Delivery System Sale Price by Company
3.4 Global Microneedle-based Drug Delivery System Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Microneedle-based Drug Delivery System Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Microneedle-based Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Microneedle-based Drug Delivery System by Regions
4.1 Microneedle-based Drug Delivery System by Regions
4.2 Americas Microneedle-based Drug Delivery System Consumption Growth
4.3 APAC Microneedle-based Drug Delivery System Consumption Growth
4.4 Europe Microneedle-based Drug Delivery System Consumption Growth
4.5 Middle East & Africa Microneedle-based Drug Delivery System Consumption Growth
5 Americas
5.1 Americas Microneedle-based Drug Delivery System Consumption by Countries
5.1.1 Americas Microneedle-based Drug Delivery System Consumption by Countries (2015-2020)
5.1.2 Americas Microneedle-based Drug Delivery System Value by Countries (2015-2020)
5.2 Americas Microneedle-based Drug Delivery System Consumption by Type
5.3 Americas Microneedle-based Drug Delivery System Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Microneedle-based Drug Delivery System Consumption by Regions
6.1.1 APAC Microneedle-based Drug Delivery System Consumption by Regions (2015-2020)
6.1.2 APAC Microneedle-based Drug Delivery System Value by Regions (2015-2020)
6.2 APAC Microneedle-based Drug Delivery System Consumption by Type
6.3 APAC Microneedle-based Drug Delivery System Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Microneedle-based Drug Delivery System by Countries
7.1.1 Europe Microneedle-based Drug Delivery System Consumption by Countries (2015-2020)
7.1.2 Europe Microneedle-based Drug Delivery System Value by Countries (2015-2020)
7.2 Europe Microneedle-based Drug Delivery System Consumption by Type
7.3 Europe Microneedle-based Drug Delivery System Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Microneedle-based Drug Delivery System by Countries
8.1.1 Middle East & Africa Microneedle-based Drug Delivery System Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Microneedle-based Drug Delivery System Value by Countries (2015-2020)
8.2 Middle East & Africa Microneedle-based Drug Delivery System Consumption by Type
8.3 Middle East & Africa Microneedle-based Drug Delivery System Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Microneedle-based Drug Delivery System Distributors
10.3 Microneedle-based Drug Delivery System Customer
11 Global Microneedle-based Drug Delivery System Market Forecast
11.1 Global Microneedle-based Drug Delivery System Consumption Forecast (2021-2025)
11.2 Global Microneedle-based Drug Delivery System Forecast by Regions
11.2.1 Global Microneedle-based Drug Delivery System Forecast by Regions (2021-2025)
11.2.2 Global Microneedle-based Drug Delivery System Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Microneedle-based Drug Delivery System Forecast by Type
11.8 Global Microneedle-based Drug Delivery System Forecast by Application
12 Key Players Analysis
12.1 3M
12.1.1 Company Information
12.1.2 Microneedle-based Drug Delivery System Product Offered
12.1.3 3M Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 3M Latest Developments
12.2 Vaxxas
12.2.1 Company Information
12.2.2 Microneedle-based Drug Delivery System Product Offered
12.2.3 Vaxxas Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Vaxxas Latest Developments
12.3 Zosano Pharma
12.3.1 Company Information
12.3.2 Microneedle-based Drug Delivery System Product Offered
12.3.3 Zosano Pharma Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Zosano Pharma Latest Developments
12.4 Nanopass Technologies
12.4.1 Company Information
12.4.2 Microneedle-based Drug Delivery System Product Offered
12.4.3 Nanopass Technologies Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Nanopass Technologies Latest Developments
12.5 Corium
12.5.1 Company Information
12.5.2 Microneedle-based Drug Delivery System Product Offered
12.5.3 Corium Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Corium Latest Developments
12.6 Becton-Dickinson_BD_Technologies
12.6.1 Company Information
12.6.2 Microneedle-based Drug Delivery System Product Offered
12.6.3 Becton-Dickinson_BD_Technologies Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Becton-Dickinson_BD_Technologies Latest Developments
12.7 Microdermics
12.7.1 Company Information
12.7.2 Microneedle-based Drug Delivery System Product Offered
12.7.3 Microdermics Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Microdermics Latest Developments
12.8 Valeritas
12.8.1 Company Information
12.8.2 Microneedle-based Drug Delivery System Product Offered
12.8.3 Valeritas Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Valeritas Latest Developments
12.9 TheraJect
12.9.1 Company Information
12.9.2 Microneedle-based Drug Delivery System Product Offered
12.9.3 TheraJect Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 TheraJect Latest Developments
12.10 Nitto
12.10.1 Company Information
12.10.2 Microneedle-based Drug Delivery System Product Offered
12.10.3 Nitto Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Nitto Latest Developments
12.11 Lohmann Therapie-Systeme AG
12.11.1 Company Information
12.11.2 Microneedle-based Drug Delivery System Product Offered
12.11.3 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Lohmann Therapie-Systeme AG Latest Developments
13 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microneedle-based Drug Delivery System Consumption 2015-2025
2.1.2 Microneedle-based Drug Delivery System Consumption CAGR by Region
2.2 Microneedle-based Drug Delivery System Segment by Type
2.2.1 Hollow Microneedle Technology
2.2.2 Solid Microneedle Technology
2.2.3 Dissolving Microneedles Technology
2.3 Microneedle-based Drug Delivery System Consumption by Type
2.3.1 Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
2.3.2 Global Microneedle-based Drug Delivery System Revenue and Market Share by Type (2015-2020)
2.3.3 Global Microneedle-based Drug Delivery System Sale Price by Type (2015-2020)
2.4 Microneedle-based Drug Delivery System Segment by Application
2.4.1 Drug Delivery
2.4.2 Vaccine Delivery
2.4.3 Other
2.5 Microneedle-based Drug Delivery System Consumption by Application
2.5.1 Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
2.5.2 Global Microneedle-based Drug Delivery System Value and Market Share by Type (2015-2020)
2.5.3 Global Microneedle-based Drug Delivery System Sale Price by Type (2015-2020)
3 Global Microneedle-based Drug Delivery System by Company
3.1 Global Microneedle-based Drug Delivery System Sales Market Share by Company
3.1.1 Global Microneedle-based Drug Delivery System Sales by Company (2018-2020)
3.1.2 Global Microneedle-based Drug Delivery System Sales Market Share by Company (2018-2020)
3.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Company
3.2.1 Global Microneedle-based Drug Delivery System Revenue by Company (2018-2020)
3.2.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Company (2018-2020)
3.3 Global Microneedle-based Drug Delivery System Sale Price by Company
3.4 Global Microneedle-based Drug Delivery System Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Microneedle-based Drug Delivery System Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Microneedle-based Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Microneedle-based Drug Delivery System by Regions
4.1 Microneedle-based Drug Delivery System by Regions
4.2 Americas Microneedle-based Drug Delivery System Consumption Growth
4.3 APAC Microneedle-based Drug Delivery System Consumption Growth
4.4 Europe Microneedle-based Drug Delivery System Consumption Growth
4.5 Middle East & Africa Microneedle-based Drug Delivery System Consumption Growth
5 Americas
5.1 Americas Microneedle-based Drug Delivery System Consumption by Countries
5.1.1 Americas Microneedle-based Drug Delivery System Consumption by Countries (2015-2020)
5.1.2 Americas Microneedle-based Drug Delivery System Value by Countries (2015-2020)
5.2 Americas Microneedle-based Drug Delivery System Consumption by Type
5.3 Americas Microneedle-based Drug Delivery System Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Microneedle-based Drug Delivery System Consumption by Regions
6.1.1 APAC Microneedle-based Drug Delivery System Consumption by Regions (2015-2020)
6.1.2 APAC Microneedle-based Drug Delivery System Value by Regions (2015-2020)
6.2 APAC Microneedle-based Drug Delivery System Consumption by Type
6.3 APAC Microneedle-based Drug Delivery System Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Microneedle-based Drug Delivery System by Countries
7.1.1 Europe Microneedle-based Drug Delivery System Consumption by Countries (2015-2020)
7.1.2 Europe Microneedle-based Drug Delivery System Value by Countries (2015-2020)
7.2 Europe Microneedle-based Drug Delivery System Consumption by Type
7.3 Europe Microneedle-based Drug Delivery System Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Microneedle-based Drug Delivery System by Countries
8.1.1 Middle East & Africa Microneedle-based Drug Delivery System Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Microneedle-based Drug Delivery System Value by Countries (2015-2020)
8.2 Middle East & Africa Microneedle-based Drug Delivery System Consumption by Type
8.3 Middle East & Africa Microneedle-based Drug Delivery System Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Microneedle-based Drug Delivery System Distributors
10.3 Microneedle-based Drug Delivery System Customer
11 Global Microneedle-based Drug Delivery System Market Forecast
11.1 Global Microneedle-based Drug Delivery System Consumption Forecast (2021-2025)
11.2 Global Microneedle-based Drug Delivery System Forecast by Regions
11.2.1 Global Microneedle-based Drug Delivery System Forecast by Regions (2021-2025)
11.2.2 Global Microneedle-based Drug Delivery System Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Microneedle-based Drug Delivery System Forecast by Type
11.8 Global Microneedle-based Drug Delivery System Forecast by Application
12 Key Players Analysis
12.1 3M
12.1.1 Company Information
12.1.2 Microneedle-based Drug Delivery System Product Offered
12.1.3 3M Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 3M Latest Developments
12.2 Vaxxas
12.2.1 Company Information
12.2.2 Microneedle-based Drug Delivery System Product Offered
12.2.3 Vaxxas Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Vaxxas Latest Developments
12.3 Zosano Pharma
12.3.1 Company Information
12.3.2 Microneedle-based Drug Delivery System Product Offered
12.3.3 Zosano Pharma Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Zosano Pharma Latest Developments
12.4 Nanopass Technologies
12.4.1 Company Information
12.4.2 Microneedle-based Drug Delivery System Product Offered
12.4.3 Nanopass Technologies Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Nanopass Technologies Latest Developments
12.5 Corium
12.5.1 Company Information
12.5.2 Microneedle-based Drug Delivery System Product Offered
12.5.3 Corium Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Corium Latest Developments
12.6 Becton-Dickinson_BD_Technologies
12.6.1 Company Information
12.6.2 Microneedle-based Drug Delivery System Product Offered
12.6.3 Becton-Dickinson_BD_Technologies Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Becton-Dickinson_BD_Technologies Latest Developments
12.7 Microdermics
12.7.1 Company Information
12.7.2 Microneedle-based Drug Delivery System Product Offered
12.7.3 Microdermics Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Microdermics Latest Developments
12.8 Valeritas
12.8.1 Company Information
12.8.2 Microneedle-based Drug Delivery System Product Offered
12.8.3 Valeritas Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Valeritas Latest Developments
12.9 TheraJect
12.9.1 Company Information
12.9.2 Microneedle-based Drug Delivery System Product Offered
12.9.3 TheraJect Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 TheraJect Latest Developments
12.10 Nitto
12.10.1 Company Information
12.10.2 Microneedle-based Drug Delivery System Product Offered
12.10.3 Nitto Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Nitto Latest Developments
12.11 Lohmann Therapie-Systeme AG
12.11.1 Company Information
12.11.2 Microneedle-based Drug Delivery System Product Offered
12.11.3 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Lohmann Therapie-Systeme AG Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Microneedle-based Drug Delivery System Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Hollow Microneedle Technology
Table 5. Major Players of Solid Microneedle Technology
Table 6. Major Players of Dissolving Microneedles Technology
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 9. Global Microneedle-based Drug Delivery System Revenue by Type (2015-2020) ($ million)
Table 10. Global Microneedle-based Drug Delivery System Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Microneedle-based Drug Delivery System Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 14. Global Microneedle-based Drug Delivery System Value by Application (2015-2020)
Table 15. Global Microneedle-based Drug Delivery System Value Market Share by Application (2015-2020)
Table 16. Global Microneedle-based Drug Delivery System Sale Price by Application (2015-2020)
Table 17. Global Microneedle-based Drug Delivery System Sales by Company (2017-2019) (K Units)
Table 18. Global Microneedle-based Drug Delivery System Sales Market Share by Company (2017-2019)
Table 19. Global Microneedle-based Drug Delivery System Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Microneedle-based Drug Delivery System Revenue Market Share by Company (2017-2019)
Table 21. Global Microneedle-based Drug Delivery System Sale Price by Company (2017-2019)
Table 22. Global Microneedle-based Drug Delivery System Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Microneedle-based Drug Delivery System Products Offered
Table 24. Microneedle-based Drug Delivery System Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Microneedle-based Drug Delivery System Consumption by Regions 2015-2020 (K Units)
Table 26. Global Microneedle-based Drug Delivery System Consumption Market Share by Regions 2015-2020
Table 27. Global Microneedle-based Drug Delivery System Value by Regions 2015-2020 ($ Millions)
Table 28. Global Microneedle-based Drug Delivery System Value Market Share by Regions 2015-2020
Table 29. Americas Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 31. Americas Microneedle-based Drug Delivery System Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Microneedle-based Drug Delivery System Value Market Share by Countries (2015-2020)
Table 33. Americas Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 34. Americas Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 35. Americas Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 36. Americas Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 37. APAC Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 39. APAC Microneedle-based Drug Delivery System Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Microneedle-based Drug Delivery System Value Market Share by Regions (2015-2020)
Table 41. APAC Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 42. APAC Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 43. APAC Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 44. APAC Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 45. Europe Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 47. Europe Microneedle-based Drug Delivery System Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Microneedle-based Drug Delivery System Value Market Share by Countries (2015-2020)
Table 49. Europe Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 50. Europe Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 51. Europe Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 52. Europe Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Microneedle-based Drug Delivery System Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Microneedle-based Drug Delivery System Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 61. Microneedle-based Drug Delivery System Distributors List
Table 62. Microneedle-based Drug Delivery System Customer List
Table 63. Global Microneedle-based Drug Delivery System Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Microneedle-based Drug Delivery System Consumption Market Forecast by Regions
Table 65. Global Microneedle-based Drug Delivery System Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Microneedle-based Drug Delivery System Value Market Share Forecast by Regions
Table 67. Global Microneedle-based Drug Delivery System Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Microneedle-based Drug Delivery System Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Microneedle-based Drug Delivery System Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Microneedle-based Drug Delivery System Value Market Share Forecast by Type (2021-2025)
Table 71. Global Microneedle-based Drug Delivery System Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Microneedle-based Drug Delivery System Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Microneedle-based Drug Delivery System Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Microneedle-based Drug Delivery System Value Market Share Forecast by Application (2021-2025)
Table 75. 3M Product Offered
Table 76. 3M Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. 3M Main Business
Table 78. 3M Latest Developments
Table 79. 3M Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 80. Vaxxas Product Offered
Table 81. Vaxxas Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Vaxxas Main Business
Table 83. Vaxxas Latest Developments
Table 84. Vaxxas Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 85. Zosano Pharma Product Offered
Table 86. Zosano Pharma Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. Zosano Pharma Main Business
Table 88. Zosano Pharma Latest Developments
Table 89. Zosano Pharma Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 90. Nanopass Technologies Product Offered
Table 91. Nanopass Technologies Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Nanopass Technologies Main Business
Table 93. Nanopass Technologies Latest Developments
Table 94. Nanopass Technologies Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 95. Corium Product Offered
Table 96. Corium Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. Corium Main Business
Table 98. Corium Latest Developments
Table 99. Corium Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 100. Becton-Dickinson_BD_Technologies Product Offered
Table 101. Becton-Dickinson_BD_Technologies Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. Becton-Dickinson_BD_Technologies Main Business
Table 103. Becton-Dickinson_BD_Technologies Latest Developments
Table 104. Becton-Dickinson_BD_Technologies Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 105. Microdermics Product Offered
Table 106. Microdermics Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 107. Microdermics Main Business
Table 108. Microdermics Latest Developments
Table 109. Microdermics Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 110. Valeritas Product Offered
Table 111. Valeritas Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Valeritas Main Business
Table 113. Valeritas Latest Developments
Table 114. Valeritas Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 115. TheraJect Product Offered
Table 116. TheraJect Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 117. TheraJect Main Business
Table 118. TheraJect Latest Developments
Table 119. TheraJect Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 120. Nitto Product Offered
Table 121. Nitto Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 122. Nitto Main Business
Table 123. Nitto Latest Developments
Table 124. Nitto Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 125. Lohmann Therapie-Systeme AG Product Offered
Table 126. Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 127. Lohmann Therapie-Systeme AG Main Business
Table 128. Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Lohmann Therapie-Systeme AG Latest Developments
List of Figures
Figure 1. Picture of Microneedle-based Drug Delivery System
Figure 2. Microneedle-based Drug Delivery System Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Microneedle-based Drug Delivery System Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Microneedle-based Drug Delivery System Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hollow Microneedle Technology
Figure 7. Product Picture of Solid Microneedle Technology
Figure 8. Product Picture of Dissolving Microneedles Technology
Figure 9. Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Figure 10. Global Microneedle-based Drug Delivery System Value Market Share by Type (2015-2020)
Figure 11. Microneedle-based Drug Delivery System Consumed in Drug Delivery
Figure 12. Global Microneedle-based Drug Delivery System Market: Drug Delivery (2015-2020) (K Units)
Figure 13. Global Microneedle-based Drug Delivery System Market: Drug Delivery (2015-2020) ($ Millions)
Figure 14. Microneedle-based Drug Delivery System Consumed in Vaccine Delivery
Figure 15. Global Microneedle-based Drug Delivery System Market: Vaccine Delivery (2015-2020) (K Units)
Figure 16. Global Microneedle-based Drug Delivery System Market: Vaccine Delivery (2015-2020) ($ Millions)
Figure 17. Microneedle-based Drug Delivery System Consumed in Other
Figure 18. Global Microneedle-based Drug Delivery System Market: Other (2015-2020) (K Units)
Figure 19. Global Microneedle-based Drug Delivery System Market: Other (2015-2020) ($ Millions)
Figure 20. Global Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Figure 21. Global Microneedle-based Drug Delivery System Value Market Share by Application (2015-2020)
Figure 22. Global Microneedle-based Drug Delivery System Sales Market Share by Company in 2017
Figure 23. Global Microneedle-based Drug Delivery System Sales Market Share by Company in 2019
Figure 24. Global Microneedle-based Drug Delivery System Revenue Market Share by Company in 2017
Figure 25. Global Microneedle-based Drug Delivery System Revenue Market Share by Company in 2019
Figure 26. Global Microneedle-based Drug Delivery System Sale Price by Company in 2019
Figure 27. Global Microneedle-based Drug Delivery System Consumption Market Share by Regions 2015-2020
Figure 28. Global Microneedle-based Drug Delivery System Value Market Share by Regions 2015-2020
Figure 29. Americas Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 30. Americas Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 31. APAC Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 32. APAC Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 33. Europe Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 34. Europe Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 37. Americas Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 38. Americas Microneedle-based Drug Delivery System Value Market Share by Countries in 2019
Figure 39. Americas Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 40. Americas Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 41. United States Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 42. United States Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 48. APAC Microneedle-based Drug Delivery System Value Market Share by Regions in 2019
Figure 49. APAC Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 50. APAC Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 51. China Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 52. China Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 59. India Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 60. India Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 64. Europe Microneedle-based Drug Delivery System Value Market Share by Countries in 2019
Figure 65. Europe Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 66. Europe Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 67. Germany Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 69. France Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 70. France Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 71. UK Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 72. UK Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Microneedle-based Drug Delivery System Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 81. Egypt Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 91. Global Microneedle-based Drug Delivery System Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Microneedle-based Drug Delivery System Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 94. Americas Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 95. APAC Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 96. APAC Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 97. Europe Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 98. Europe Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 101. United States Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 102. United States Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 103. Canada Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 104. Canada Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 105. Mexico Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 106. Mexico Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 107. Brazil Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 108. Brazil Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 109. China Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 110. China Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 111. Japan Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 112. Japan Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 113. Korea Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 114. Korea Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 117. India Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 118. India Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 119. Australia Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 120. Australia Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 121. Germany Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 122. Germany Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 123. France Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 124. France Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 125. UK Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 126. UK Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 127. Italy Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 128. Italy Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 129. Russia Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 130. Russia Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 131. Spain Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 132. Spain Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 133. Egypt Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 134. Egypt Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 135. South Africa Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 136. South Africa Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 137. Israel Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 138. Israel Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 139. Turkey Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 140. Turkey Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 143. 3M Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 144. Vaxxas Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 145. Zosano Pharma Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 146. Nanopass Technologies Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 147. Corium Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 148. Becton-Dickinson_BD_Technologies Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 149. Microdermics Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 150. Valeritas Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 151. TheraJect Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 152. Nitto Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 153. Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Market Share (2018-2020)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Microneedle-based Drug Delivery System Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Hollow Microneedle Technology
Table 5. Major Players of Solid Microneedle Technology
Table 6. Major Players of Dissolving Microneedles Technology
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 9. Global Microneedle-based Drug Delivery System Revenue by Type (2015-2020) ($ million)
Table 10. Global Microneedle-based Drug Delivery System Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Microneedle-based Drug Delivery System Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 14. Global Microneedle-based Drug Delivery System Value by Application (2015-2020)
Table 15. Global Microneedle-based Drug Delivery System Value Market Share by Application (2015-2020)
Table 16. Global Microneedle-based Drug Delivery System Sale Price by Application (2015-2020)
Table 17. Global Microneedle-based Drug Delivery System Sales by Company (2017-2019) (K Units)
Table 18. Global Microneedle-based Drug Delivery System Sales Market Share by Company (2017-2019)
Table 19. Global Microneedle-based Drug Delivery System Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Microneedle-based Drug Delivery System Revenue Market Share by Company (2017-2019)
Table 21. Global Microneedle-based Drug Delivery System Sale Price by Company (2017-2019)
Table 22. Global Microneedle-based Drug Delivery System Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Microneedle-based Drug Delivery System Products Offered
Table 24. Microneedle-based Drug Delivery System Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Microneedle-based Drug Delivery System Consumption by Regions 2015-2020 (K Units)
Table 26. Global Microneedle-based Drug Delivery System Consumption Market Share by Regions 2015-2020
Table 27. Global Microneedle-based Drug Delivery System Value by Regions 2015-2020 ($ Millions)
Table 28. Global Microneedle-based Drug Delivery System Value Market Share by Regions 2015-2020
Table 29. Americas Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 31. Americas Microneedle-based Drug Delivery System Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Microneedle-based Drug Delivery System Value Market Share by Countries (2015-2020)
Table 33. Americas Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 34. Americas Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 35. Americas Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 36. Americas Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 37. APAC Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 39. APAC Microneedle-based Drug Delivery System Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Microneedle-based Drug Delivery System Value Market Share by Regions (2015-2020)
Table 41. APAC Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 42. APAC Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 43. APAC Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 44. APAC Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 45. Europe Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 47. Europe Microneedle-based Drug Delivery System Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Microneedle-based Drug Delivery System Value Market Share by Countries (2015-2020)
Table 49. Europe Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 50. Europe Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 51. Europe Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 52. Europe Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Microneedle-based Drug Delivery System Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Microneedle-based Drug Delivery System Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Microneedle-based Drug Delivery System Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Microneedle-based Drug Delivery System Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Microneedle-based Drug Delivery System Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Table 61. Microneedle-based Drug Delivery System Distributors List
Table 62. Microneedle-based Drug Delivery System Customer List
Table 63. Global Microneedle-based Drug Delivery System Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Microneedle-based Drug Delivery System Consumption Market Forecast by Regions
Table 65. Global Microneedle-based Drug Delivery System Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Microneedle-based Drug Delivery System Value Market Share Forecast by Regions
Table 67. Global Microneedle-based Drug Delivery System Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Microneedle-based Drug Delivery System Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Microneedle-based Drug Delivery System Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Microneedle-based Drug Delivery System Value Market Share Forecast by Type (2021-2025)
Table 71. Global Microneedle-based Drug Delivery System Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Microneedle-based Drug Delivery System Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Microneedle-based Drug Delivery System Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Microneedle-based Drug Delivery System Value Market Share Forecast by Application (2021-2025)
Table 75. 3M Product Offered
Table 76. 3M Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. 3M Main Business
Table 78. 3M Latest Developments
Table 79. 3M Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 80. Vaxxas Product Offered
Table 81. Vaxxas Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Vaxxas Main Business
Table 83. Vaxxas Latest Developments
Table 84. Vaxxas Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 85. Zosano Pharma Product Offered
Table 86. Zosano Pharma Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. Zosano Pharma Main Business
Table 88. Zosano Pharma Latest Developments
Table 89. Zosano Pharma Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 90. Nanopass Technologies Product Offered
Table 91. Nanopass Technologies Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Nanopass Technologies Main Business
Table 93. Nanopass Technologies Latest Developments
Table 94. Nanopass Technologies Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 95. Corium Product Offered
Table 96. Corium Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. Corium Main Business
Table 98. Corium Latest Developments
Table 99. Corium Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 100. Becton-Dickinson_BD_Technologies Product Offered
Table 101. Becton-Dickinson_BD_Technologies Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. Becton-Dickinson_BD_Technologies Main Business
Table 103. Becton-Dickinson_BD_Technologies Latest Developments
Table 104. Becton-Dickinson_BD_Technologies Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 105. Microdermics Product Offered
Table 106. Microdermics Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 107. Microdermics Main Business
Table 108. Microdermics Latest Developments
Table 109. Microdermics Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 110. Valeritas Product Offered
Table 111. Valeritas Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Valeritas Main Business
Table 113. Valeritas Latest Developments
Table 114. Valeritas Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 115. TheraJect Product Offered
Table 116. TheraJect Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 117. TheraJect Main Business
Table 118. TheraJect Latest Developments
Table 119. TheraJect Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 120. Nitto Product Offered
Table 121. Nitto Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 122. Nitto Main Business
Table 123. Nitto Latest Developments
Table 124. Nitto Basic Information, Company Total Revenue (in $ million), Microneedle-based Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 125. Lohmann Therapie-Systeme AG Product Offered
Table 126. Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 127. Lohmann Therapie-Systeme AG Main Business
Table 128. Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Lohmann Therapie-Systeme AG Latest Developments
List of Figures
Figure 1. Picture of Microneedle-based Drug Delivery System
Figure 2. Microneedle-based Drug Delivery System Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Microneedle-based Drug Delivery System Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Microneedle-based Drug Delivery System Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hollow Microneedle Technology
Figure 7. Product Picture of Solid Microneedle Technology
Figure 8. Product Picture of Dissolving Microneedles Technology
Figure 9. Global Microneedle-based Drug Delivery System Consumption Market Share by Type (2015-2020)
Figure 10. Global Microneedle-based Drug Delivery System Value Market Share by Type (2015-2020)
Figure 11. Microneedle-based Drug Delivery System Consumed in Drug Delivery
Figure 12. Global Microneedle-based Drug Delivery System Market: Drug Delivery (2015-2020) (K Units)
Figure 13. Global Microneedle-based Drug Delivery System Market: Drug Delivery (2015-2020) ($ Millions)
Figure 14. Microneedle-based Drug Delivery System Consumed in Vaccine Delivery
Figure 15. Global Microneedle-based Drug Delivery System Market: Vaccine Delivery (2015-2020) (K Units)
Figure 16. Global Microneedle-based Drug Delivery System Market: Vaccine Delivery (2015-2020) ($ Millions)
Figure 17. Microneedle-based Drug Delivery System Consumed in Other
Figure 18. Global Microneedle-based Drug Delivery System Market: Other (2015-2020) (K Units)
Figure 19. Global Microneedle-based Drug Delivery System Market: Other (2015-2020) ($ Millions)
Figure 20. Global Microneedle-based Drug Delivery System Consumption Market Share by Application (2015-2020)
Figure 21. Global Microneedle-based Drug Delivery System Value Market Share by Application (2015-2020)
Figure 22. Global Microneedle-based Drug Delivery System Sales Market Share by Company in 2017
Figure 23. Global Microneedle-based Drug Delivery System Sales Market Share by Company in 2019
Figure 24. Global Microneedle-based Drug Delivery System Revenue Market Share by Company in 2017
Figure 25. Global Microneedle-based Drug Delivery System Revenue Market Share by Company in 2019
Figure 26. Global Microneedle-based Drug Delivery System Sale Price by Company in 2019
Figure 27. Global Microneedle-based Drug Delivery System Consumption Market Share by Regions 2015-2020
Figure 28. Global Microneedle-based Drug Delivery System Value Market Share by Regions 2015-2020
Figure 29. Americas Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 30. Americas Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 31. APAC Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 32. APAC Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 33. Europe Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 34. Europe Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Microneedle-based Drug Delivery System Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Microneedle-based Drug Delivery System Value 2015-2020 ($ Millions)
Figure 37. Americas Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 38. Americas Microneedle-based Drug Delivery System Value Market Share by Countries in 2019
Figure 39. Americas Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 40. Americas Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 41. United States Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 42. United States Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 48. APAC Microneedle-based Drug Delivery System Value Market Share by Regions in 2019
Figure 49. APAC Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 50. APAC Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 51. China Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 52. China Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 59. India Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 60. India Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 64. Europe Microneedle-based Drug Delivery System Value Market Share by Countries in 2019
Figure 65. Europe Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 66. Europe Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 67. Germany Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 69. France Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 70. France Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 71. UK Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 72. UK Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Microneedle-based Drug Delivery System Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Microneedle-based Drug Delivery System Consumption Market Share by Application in 2019
Figure 81. Egypt Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Microneedle-based Drug Delivery System Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Microneedle-based Drug Delivery System Value Growth 2015-2020 ($ Millions)
Figure 91. Global Microneedle-based Drug Delivery System Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Microneedle-based Drug Delivery System Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 94. Americas Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 95. APAC Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 96. APAC Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 97. Europe Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 98. Europe Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 101. United States Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 102. United States Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 103. Canada Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 104. Canada Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 105. Mexico Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 106. Mexico Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 107. Brazil Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 108. Brazil Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 109. China Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 110. China Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 111. Japan Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 112. Japan Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 113. Korea Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 114. Korea Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 117. India Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 118. India Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 119. Australia Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 120. Australia Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 121. Germany Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 122. Germany Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 123. France Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 124. France Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 125. UK Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 126. UK Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 127. Italy Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 128. Italy Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 129. Russia Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 130. Russia Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 131. Spain Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 132. Spain Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 133. Egypt Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 134. Egypt Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 135. South Africa Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 136. South Africa Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 137. Israel Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 138. Israel Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 139. Turkey Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 140. Turkey Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Microneedle-based Drug Delivery System Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Microneedle-based Drug Delivery System Value 2021-2025 ($ Millions)
Figure 143. 3M Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 144. Vaxxas Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 145. Zosano Pharma Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 146. Nanopass Technologies Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 147. Corium Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 148. Becton-Dickinson_BD_Technologies Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 149. Microdermics Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 150. Valeritas Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 151. TheraJect Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 152. Nitto Microneedle-based Drug Delivery System Market Share (2018-2020)
Figure 153. Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Market Share (2018-2020)
